Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and Drug Administration request to stop selling a drug tied to three deaths.
Source link
Sarepta stock extends decline as company declines FDA call to withdraw drug
By Daniel snow
